Regulated Information - Global

Regulated Information

Filter

Period

Filter by

recent search

Showing: 105 of 152 Regulated Information

Ipsen completes acquisition of Albireo,  expanding the scope of its Rare Disease portfolio
Ipsen completes acquisition of Albireo, expanding the scope of its Rare Disease portfolio

PARIS, FRANCE, 3 March 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced it has completed the acquisition of Albireo Pharma, Inc., a leading innovator in bile-acid modulators to treat rare liver conditions. The acquisition enriches Ipsen’s Rare Disease portfolio, with…


Voting rights on 31 January 2023
Voting rights on 31 January 2023

This article or press release has no online content. Please download the associated documents for more information.


Ipsen extends expiration date of tender offer for Albireo Pharma, Inc. to 1 March 2023
Ipsen extends expiration date of tender offer for Albireo Pharma, Inc. to 1 March 2023

PARIS, FRANCE, 22 February 2023 – Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Anemone Acquisition Corp. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued…



IPSEN: Monthly information relative to the total number of voting rights  and shares composing the share capital
IPSEN: Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital


1 17 18 19 20 21 22 23 31